Spontaneous tumor lysis syndrome (STLS) is a rare oncologic emergency caused by
massive cancer cell lysis or necrosis without a precipitating factor. Although tumor lysis …

Tumor lysis syndrome is a well-described, serious complication of chemotherapy
administered to treat malignancies. However, a very rare event resulting in the spontaneous …

Tumor lysis syndrome (TLS) is an oncologic emergency characterized by the destruction of
tumor cells leading to an influx of large amounts of uric acid, potassium, and phosphorus …

Spontaneous tumor lysis syndrome is a rare oncological emergency associated with
multiorgan failure. It is characterized by an elevation of uric acid, hyperphosphatemia …

Spontaneous tumor lysis syndrome is a rare oncological emergency associated with
multiorgan failure. It is characterized by an elevation of uric acid, hyperphosphatemia …

Tumor lysis syndrome (TLS) is an oncologic emergency characterized by the destruction of
tumor cells leading to an influx of large amounts of uric acid, potassium, and phosphorus …

Tumor lysis syndrome (SLT) is a rare and potentially fatal entity. It represents an oncological
emergency. It can be diagnosed by its clinical presentation and also by laboratory results. In …

Tumor lysis syndrome (TLS) is a known complication of malignancy and its treatment. The
incidence varies on malignancy type, but is most common with hematologic neoplasms …

Tumor lysis syndrome (TLS) is a hemato-oncological emergency characterized by metabolic
and electrolyte imbalances which are associated with disintegrating tumor cells. The …

Tumor lysis syndrome (TLS) is a potentially life-threatening complication of chemotherapy. It
usually occurs in rapidly proliferating hematological malignancies. TLS is deemed …